Diacerein Market

Diacerein, C19H12O8, is an important inhibitor of osteoarthritis il-1.Double red vinegar by and diacetyl dihydrogen anthracene carboxylic acid, 1, 8 - acetyl 2-3 - carboxylic acid anthraquinone, ceri English, artodar, is a new inhibitor, interleukin (IL) - 1 chemical name for diacetyl rhein, belong to the compound of anthraquinones, this product can induce cartilage formation, have analgesic, anti-inflammatory and antifebrile effect, can significantly improve the joint function in patients with osteoarthritis, delay the course of the disease, relieve pain, improve the patient's quality of life, has good safety, clinical mainly used in the treatment of osteoarthritis (OA) and play a role of antibacterial.

Diacerein Market contains market size and forecasts of Diacerein in global, including the following market information:

Global Diacerein Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Diacerein Market Sales, 2017-2022, 2023-2028, (KG)

Global top five Diacerein companies in 2021 (%)

The global Diacerein market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Combination Drugs Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Diacerein include TRB Pharma, Novartis, TWi Pharma, Zydus Pharmaceuticals/Cadila Pharma, Glenmark Pharmaceutical, Castle Creek Pharma, Proter, Rottapharm and Abiogen Pharma. etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Diacerein manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Diacerein Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (KG)

Global Diacerein Market Segment Percentages, by Type, 2021 (%)

Combination Drugs

Prescribed Drugs

Global Diacerein Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (KG)

Global Diacerein Market Segment Percentages, by Application, 2021 (%)

Arthritis

Musculoskeletal Pain

Bullae Epidermolysis

Pemphigus

Pemphigoid

Other

Global Diacerein Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (KG)

Global Diacerein Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Diacerein revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Diacerein revenues share in global market, 2021 (%)

Key companies Diacerein sales in global market, 2017-2022 (Estimated), (KG)

Key companies Diacerein sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

TRB Pharma

Novartis

TWi Pharma

Zydus Pharmaceuticals/Cadila Pharma

Glenmark Pharmaceutical

Castle Creek Pharma

Proter

Rottapharm

Abiogen Pharma